Y Sun1, C Liu2, Y Bo1, J You1, Y Zhu1, D Duan1, H Cui1, Q Lu3. 1. Department of Nutrition and Food Hygiene, College of Public Health, Zhengzhou University, Zhengzhou, China. 2. The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China. 3. Department of Nutrition and Food Hygiene, College of Public Health, Zhengzhou University, Zhengzhou, China. lqjnutr@zzu.edu.cn.
Abstract
The meta-analysis suggested that dietary vitamin C was statistically inversely associated with the risk of hip fracture (overall OR = 0.73, 95% CI = 0.55-0.97, I 2 = 69.1%) and with the increase of 50 mg/day vitamin C intake, the risk of hip fracture will reduce by 5% (OR = 0.95, 95% CI 0.91-1.00, P = 0.05). INTRODUCTION: Previous studies had inconsistent findings regarding the association between vitamin C intake and the risk of hip fracture. Therefore, we conducted a meta-analysis to evaluate the association of dietary vitamin C intake and the risk of hip fracture. METHODS: Relevant studies were identified by searching PubMed, Embase, and Web of Science up to December 2016. Additional articles were identified from reviewing the reference lists of relevant articles. The summary relative risks (RRs) or odds ratios (ORs) and 95% confidence intervals (CIs) were estimated by random effects model. Funnel plot and Egger's test were used to test publication bias. RESULTS: The total six articles containing 7908 controls and 2899 cases of hip fracture were included in this meta-analysis. By comparing the highest versus the lowest categories of vitamin C intake, we found that dietary vitamin C was statistically correlated with the risk of hip fracture [overall OR = 0.73, 95% CI = 0.55-0.97, I 2 = 69.1%]. A linear dose-response association showed that the increase with vitamin C intake of 50 mg/day statistically reduced by 5% (OR = 0.95, 95% CI 0.91-1.00, P = 0.05) the risk of hip fracture. CONCLUSIONS: In conclusion, the results of current meta-analysis strongly support that increasing dietary vitamin C intake can decrease the risk of hip fracture. In order to verify the association of vitamin C intake and hip fracture risk, further well-designed largely randomized controlled trials (RCTs) are needed.
The meta-analysis suggested that dietary vitamin C was statistically inversely associated with the risk of hip fracture (overall OR = 0.73, 95% CI = 0.55-0.97, I 2 = 69.1%) and with the increase of 50 mg/day vitamin C intake, the risk of hip fracture will reduce by 5% (OR = 0.95, 95% CI 0.91-1.00, P = 0.05). INTRODUCTION: Previous studies had inconsistent findings regarding the association between vitamin C intake and the risk of hip fracture. Therefore, we conducted a meta-analysis to evaluate the association of dietary vitamin C intake and the risk of hip fracture. METHODS: Relevant studies were identified by searching PubMed, Embase, and Web of Science up to December 2016. Additional articles were identified from reviewing the reference lists of relevant articles. The summary relative risks (RRs) or odds ratios (ORs) and 95% confidence intervals (CIs) were estimated by random effects model. Funnel plot and Egger's test were used to test publication bias. RESULTS: The total six articles containing 7908 controls and 2899 cases of hip fracture were included in this meta-analysis. By comparing the highest versus the lowest categories of vitamin C intake, we found that dietary vitamin C was statistically correlated with the risk of hip fracture [overall OR = 0.73, 95% CI = 0.55-0.97, I 2 = 69.1%]. A linear dose-response association showed that the increase with vitamin C intake of 50 mg/day statistically reduced by 5% (OR = 0.95, 95% CI 0.91-1.00, P = 0.05) the risk of hip fracture. CONCLUSIONS: In conclusion, the results of current meta-analysis strongly support that increasing dietary vitamin C intake can decrease the risk of hip fracture. In order to verify the association of vitamin C intake and hip fracture risk, further well-designed largely randomized controlled trials (RCTs) are needed.
Entities:
Keywords:
Antioxidant; Dietary vitamin C; Dose-response; Hip fracture; Meta-analysis
Authors: Jianjun Zhang; Ronald G Munger; Nancy A West; D Richard Cutler; Heidi J Wengreen; Christopher D Corcoran Journal: Am J Epidemiol Date: 2005-11-23 Impact factor: 4.897
Authors: Russel Burge; Bess Dawson-Hughes; Daniel H Solomon; John B Wong; Alison King; Anna Tosteson Journal: J Bone Miner Res Date: 2007-03 Impact factor: 6.741
Authors: V Benetou; P Orfanos; U Pettersson-Kymmer; U Bergström; O Svensson; I Johansson; F Berrino; R Tumino; K B Borch; E Lund; P H M Peeters; V Grote; K Li; J M Altzibar; T Key; H Boeing; A von Ruesten; T Norat; P A Wark; E Riboli; A Trichopoulou Journal: Osteoporos Int Date: 2012-10-20 Impact factor: 4.507
Authors: Ronit Marom; Lindsay C Burrage; Rossella Venditti; Aurélie Clément; Bernardo Blanco-Sánchez; Mahim Jain; Daryl A Scott; Jill A Rosenfeld; V Reid Sutton; Marwan Shinawi; Ghayda Mirzaa; Catherine DeVile; Rowenna Roberts; Alistair D Calder; Jeremy Allgrove; Ingo Grafe; Denise G Lanza; Xiaohui Li; Kyu Sang Joeng; Yi-Chien Lee; I-Wen Song; Joseph M Sliepka; Dominyka Batkovskyte; Megan Washington; Brian C Dawson; Zixue Jin; Ming-Ming Jiang; Shan Chen; Yuqing Chen; Alyssa A Tran; Lisa T Emrick; David R Murdock; Neil A Hanchard; Gladys E Zapata; Nitesh R Mehta; Mary Ann Weis; Abbey A Scott; Brenna A Tremp; Jennifer B Phillips; Jeremy Wegner; Tashunka Taylor-Miller; Richard A Gibbs; Donna M Muzny; Shalini N Jhangiani; John Hicks; Rolf W Stottmann; Mary E Dickinson; John R Seavitt; Jason D Heaney; David R Eyre; Monte Westerfield; Maria Antonietta De Matteis; Brendan Lee Journal: Am J Hum Genet Date: 2021-08-26 Impact factor: 11.025
Authors: Roman Thaler; Farzaneh Khani; Ines Sturmlechner; Sharareh S Dehghani; Janet M Denbeigh; Xianhu Zhou; Oksana Pichurin; Amel Dudakovic; Sofia S Jerez; Jian Zhong; Jeong-Heon Lee; Ramesh Natarajan; Ivo Kalajzic; Yong-Hui Jiang; David R Deyle; Eleftherios P Paschalis; Barbara M Misof; Tamas Ordog; Andre J van Wijnen Journal: Nat Commun Date: 2022-10-06 Impact factor: 17.694
Authors: Katharina Hill-Mündel; Johannes Schlegl; Hans Konrad Biesalski; Sabrina Ehnert; Steffen Schröter; Christian Bahrs; Donatus Nohr; Andreas K Nüssler; Christoph Ihle Journal: J Clin Med Date: 2019-12-26 Impact factor: 4.241